Location History:
- Kensington, CA (US) (2008)
- Danville, CA (US) (2008)
- Princeton, NJ (US) (1994 - 2009)
Company Filing History:
16 out of 108 
2 out of 23 
1 out of 12 
Years Active: 1994-2009
Title: Ramachandran S Ranganathan - A Pioneer in Diagnostic and Therapeutic Innovations
Introduction:
Ramachandran S Ranganathan, a brilliant inventor and researcher, has made substantial contributions to the field of diagnostic and therapeutic applications. With over 20 patents to his name, Ranganathan's latest inventions have revolutionized the world of radiopharmaceuticals and selectin binding ligand conjugates. This article will delve into his latest patents, career highlights, notable collaborations, and the impact of his groundbreaking work.
Latest Patents:
Ranganathan's recent patents exemplify his proficiency in developing novel technologies to enhance diagnostic and therapeutic functions.
1. Conjugates of antioxidants with metal chelating ligands for use in diagnostic and therapeutic applications:
This invention focuses on radiopharmaceuticals for diagnostic and therapeutic purposes. Ranganathan's groundbreaking creation includes conjugates of antioxidants with metal chelating ligands, along with intermediate compounds. Additionally, methods for producing these radiopharmaceuticals, ligands, and intermediate compounds are also described. This patent opens doors to advanced applications in the medical field.
2. Linkable sialyl Lewis X analogs:
Ranganathan's second notable patent reveals a class of linkable tetrasaccharide compounds consisting of the amino phenyl glycoside of sialyl Lewis X (SLe), among other related analogs. These compounds feature conjugatable nucleophilic groups, making them instrumental in preparing multimeric SLecompositions. By linking them to a reporter moiety, such as contrast agents, radiodiagnostic agents, or cytotoxic agents, these compounds enable the diagnosis and treatment of selectin-mediated disorders and related conditions.
Career Highlights:
Throughout his illustrious career, Ranganathan has made significant contributions to the field of medical research and development. Having worked for esteemed companies such as Bracco International BV and Bracco Research, USA, Ranganathan has garnered invaluable expertise and experience.
Collaborations:
Ranganathan's collaborations with renowned researchers have undoubtedly played a crucial role in his innovative achievements. Notably, he has collaborated with Michael F Tweedle and Radhakrishna K Pillai, both respected scientists in their respective areas of expertise. These collaborations have paved the way for exceptional advancements in the development of diagnostic and therapeutic solutions.
Conclusion:
Ramachandran S Ranganathan's impressive repertoire of patents, along with his significant contributions to the field of diagnostic and therapeutic applications, solidify his position as a pioneer in the medical research domain. His inventions in radiopharmaceuticals and selectin binding ligand conjugates have revolutionized the healthcare industry, offering new ways to diagnose and treat various disorders. Ranganathan's dedication to innovation and his fruitful collaborations have undoubtedly impacted the lives of countless individuals, making him an influential figure in the realm of diagnostics and therapeutics.